印度的幽门螺杆菌感染：反对根除治疗的理由。 - Suppr

Suppr

超能文献

Helicobacter pylori infection in India: the case against eradication.

作者信息

Ramakrishna B S

机构信息

Department of Gastrointestinal Sciences, Christian Medical College, Vellore.

出版信息

Indian J Gastroenterol. 2006 Jan-Feb;25(1):25-8.

PMID:16567891

Abstract

摘要

相似文献

Helicobacter pylori infection in India: the case against eradication.

Indian J Gastroenterol. 2006 Jan-Feb;25(1):25-8.

The case for Helicobacter pylori eradication in India: sensationalism, skepticism and scientific salesmanship.

Indian J Gastroenterol. 2006 Jan-Feb;25(1):20-4.

Epidemiology of Helicobacter pylori in India.

Indian J Gastroenterol. 1997 Nov;16 Suppl 1:S3-5.

Duodenal gastric metaplasia and Helicobacter pylori infection in high and low duodenal ulcer-prevalent areas in India.

J Gastroenterol Hepatol. 2004 May;19(5):497-505. doi: 10.1111/j.1440-1746.2003.03320.x.

Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation.

Gut. 1995 Feb;36(2):198-202. doi: 10.1136/gut.36.2.198.

Prevalence of Helicobacter pylori in southern Indian controls and patients with gastroduodenal disease.

J Gastroenterol Hepatol. 1994 Sep-Oct;9(5):501-6. doi: 10.1111/j.1440-1746.1994.tb01281.x.

Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.

Eur J Gastroenterol Hepatol. 1999 Jul;11(7):721-6. doi: 10.1097/00042737-199907000-00007.

Helicobacter pylori infection.

Clin Evid. 2005 Jun(13):518-34.

Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.

Aliment Pharmacol Ther. 2005 Aug 1;22(3):243-9. doi: 10.1111/j.1365-2036.2005.02554.x.

Eradication of Helicobacter pylori: therapies and clinical implications.

Postgrad Med J. 1992 Jul;68(801):549-57. doi: 10.1136/pgmj.68.801.549.

引用本文的文献

Current paradigms in the management of refractory Helicobacter pylori infection.

Indian J Gastroenterol. 2023 Dec;42(6):766-779. doi: 10.1007/s12664-023-01448-3. Epub 2023 Sep 22.

Comprehensive Studies of Different Cancer Diseases among Less-Developed Countries.

Healthcare (Basel). 2022 Feb 24;10(3):424. doi: 10.3390/healthcare10030424.

Oral rinses in growth inhibition and treatment of Helicobacter pylori infection.

BMC Microbiol. 2020 Mar 4;20(1):45. doi: 10.1186/s12866-020-01728-4.

versus triple therapy for the eradication of in functional dyspepsia.

Med Pharm Rep. 2019 Oct;92(4):352-355. doi: 10.15386/mpr-1375. Epub 2019 Oct 25.

Exploring current status of Helicobacter pylori infection in different age groups of patients with dyspepsia.

Indian J Gastroenterol. 2017 Nov;36(6):509-513. doi: 10.1007/s12664-017-0810-0. Epub 2018 Jan 24.

Serum prolidase activity, oxidant and antioxidant status in nonulcer dyspepsia and healthy volunteers.

ISRN Biochem. 2013 Oct 29;2013:182601. doi: 10.1155/2013/182601. eCollection 2013.

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study.

Indian J Gastroenterol. 2013 Nov;32(6):392-6. doi: 10.1007/s12664-013-0357-7. Epub 2013 Oct 26.

Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans.

Nutrients. 2013 Aug 2;5(8):3062-73. doi: 10.3390/nu5083062.

Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: a randomized comparative trial.

Indian J Gastroenterol. 2013 May;32(3):190-4. doi: 10.1007/s12664-013-0304-7. Epub 2013 Mar 21.

Formulation and evaluation of floating oral in situ gelling system of amoxicillin.

ISRN Pharm. 2011;2011:276250. doi: 10.5402/2011/276250. Epub 2011 Jul 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验